ResApp founding director Brian Leedman.

ResApp starts trading on ASX

Perth-based biotech company ResApp Health had a steady first day of trade on the ASX today, after being acquired by Narhex Life Sciences in an $11 million backdoor listing.


(existing subscribers)

The password field is case sensitive.
Request new password
Included in the following lists: